Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H28F2O7 |
| Molecular Weight | 490.4931 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(O)=O
InChI
InChIKey=QOANMINPJDURAZ-VEGHOPOESA-N
InChI=1S/C26H28F2O7/c1-13-9-15-16-11-18(27)17-10-14(29)6-7-23(17,2)25(16,28)20(30)12-24(15,3)26(13,22(32)33)35-21(31)19-5-4-8-34-19/h4-8,10,13,15-16,18,20,30H,9,11-12H2,1-3H3,(H,32,33)/t13-,15+,16+,18+,20+,23+,24+,25+,26+/m1/s1
| Molecular Formula | C26H28F2O7 |
| Molecular Weight | 490.4931 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:56:12 GMT 2025
by
admin
on
Mon Mar 31 22:56:12 GMT 2025
|
| Record UNII |
1W3NSQ8V5D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
397864-63-0
Created by
admin on Mon Mar 31 22:56:12 GMT 2025 , Edited by admin on Mon Mar 31 22:56:12 GMT 2025
|
PRIMARY | |||
|
10163423
Created by
admin on Mon Mar 31 22:56:12 GMT 2025 , Edited by admin on Mon Mar 31 22:56:12 GMT 2025
|
PRIMARY | |||
|
1W3NSQ8V5D
Created by
admin on Mon Mar 31 22:56:12 GMT 2025 , Edited by admin on Mon Mar 31 22:56:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
MAJOR
PLASMA
|
||
|
PARENT -> METABOLITE INACTIVE |
Scientific Literature
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Tmax | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
| Biological Half-life | PHARMACOKINETIC |
|
IN HEALTHY MALE SUBJECTS |
|
||